Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 524: An integrative approach to unveiling biomarkers and therapeutic targets identifies novel treatment strategy for advanced prostate cancer

Shreya Shyam Sundar, Ephraim J. Gardner, Surendra Gulla, Remi Adelaiye-Ogala

Cancer Res (2025) 85 (8_Supplement_1): 524.

https://doi.org/10.1158/1538-7445.AM2025-524

Published: 21 April 2025

View articletitled, Abstract 524: An integrative approach to unveiling biomarkers and therapeutic targets identifies novel treatment strategy for advanced prostate cancer

Journal Articles

Abstract 4409: Exploring PBX1's role in enzalutamide resistance in advanced prostate cancer

Ephraim J. Gardner, Surendra Gulla, Leslie McClinton, Jonathan E. Bard, Remi Adelaiye-Ogala

Cancer Res (2025) 85 (8_Supplement_1): 4409.

https://doi.org/10.1158/1538-7445.AM2025-4409

Published: 21 April 2025

View articletitled, Abstract 4409: Exploring PBX1's role in enzalutamide resistance in advanced prostate cancer

Journal Articles

Abstract 6823: Dynamics of KMT2D modulation of the PI3K-Akt pathway and the impact on metastasis in prostate cancer

Abbas Jawadwala, Surrendra Gulla, Remi Adelaiye-Ogala

Cancer Res (2025) 85 (8_Supplement_1): 6823.

https://doi.org/10.1158/1538-7445.AM2025-6823

Published: 21 April 2025

View articletitled, Abstract 6823: Dynamics of KMT2D modulation of the PI3K-Akt pathway and the impact on metastasis in prostate cancer

Journal Articles

Abstract 1324: MECOM a novel player in AR-driven treatment resistant castration-resistant prostate cancer

Surendra Gulla, Tej K. Sharma, Ephraim Gardner, Shreya Shyam Sundar, Brian Capaldo, Jonathan E. Bard, Tobi Ogunbowale, Abbas Jawadala, Min Ma, Roberto Pili, Jun Qu, David J. VanderWeele, Remi Adelaiye-Ogala

Cancer Res (2025) 85 (8_Supplement_1): 1324.

https://doi.org/10.1158/1538-7445.AM2025-1324

Published: 21 April 2025

View articletitled, Abstract 1324: MECOM a novel player in AR-driven treatment resistant castration-resistant prostate cancer

Journal Articles

Abstract 7584: The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma

Abbas Jawadwala, Christopher Rupert, Remi Adelaiye-Ogala, Roberto Pili, Sreenivasulu Chintala, Ashley Orillion, May Elbanna, Nur Damayanti, Ilaria Delle Fontane

Cancer Res (2024) 84 (6_Supplement): 7584.

https://doi.org/10.1158/1538-7445.AM2024-7584

Published: 22 March 2024

View articletitled, Abstract 7584: The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma

Journal Articles

Abstract 1953: Posttranslational modification in glucocorticoid receptor in treatment resistant prostate cancers

Surendra Gulla, Ephraim Gardner, Shreya Shyam Sundar, Praveen Jaiswal, Ning Gao, Lynda Bennet, Suzanne Conzen, Remi Adelaiye-Ogala

Cancer Res (2024) 84 (6_Supplement): 1953.

https://doi.org/10.1158/1538-7445.AM2024-1953

Published: 22 March 2024

View articletitled, Abstract 1953: Posttranslational modification in glucocorticoid receptor in treatment resistant prostate cancers

Journal Articles

Abstract B003: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer

Surendra Gulla, Jonathan E. Bard, David J. VanderWeele, Kathleen Kelly, Remi Adelaiye-Ogala

Cancer Res (2023) 83 (11_Supplement): B003.

https://doi.org/10.1158/1538-7445.PRCA2023-B003

Published: 02 June 2023

View articletitled, Abstract B003: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer

Journal Articles

Abstract 3989: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer

Surendra Gulla, Jonathan E. Bard, David J. VanderWeele, Kathleen Kelly, Remi Adelaiye-Ogala

Cancer Res (2023) 83 (7_Supplement): 3989.

https://doi.org/10.1158/1538-7445.AM2023-3989

Published: 04 April 2023

View articletitled, Abstract 3989: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer

Journal Articles

Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

May Elbanna, Justin Budka, Paige Dausinas, Remi Adelaiye-Ogala, Nur Damayanti, Ashley Orillion, Eri Banno, Luigi Fontana, Roberto Pili

Cancer Res (2019) 79 (13_Supplement): 1611.

https://doi.org/10.1158/1538-7445.AM2019-1611

Published: 01 July 2019

View articletitled, Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

Journal Articles

Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma

Remi Adelaiye-Ogala, Nur P. Damayanti, Ashley R. Orillion, Sreevani Arisa, Sreenivasulu Chintala, Mark A. Titus, Chinghai Kao, Roberto Pili

Cancer Res (2018) 78 (11): 2886–2896.

https://doi.org/10.1158/0008-5472.CAN-17-3386

Published: 31 May 2018

View articletitled, Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma

Includes: Multimedia, Supplementary data

Journal Articles

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Cancer Res (2017) 77 (23): 6651–6666.

https://doi.org/10.1158/0008-5472.CAN-17-0899

Published: 30 November 2017

View articletitled, EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Includes: Supplementary data

Journal Articles

Abstract 250: Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth

Ashley R. Orillion, Sreenivasulu Chintala, Remi Adelaiye-Ogala, Li Shen, Nur Damayanti, May Elbanna, Sreevani Arisa, Bennett Elzey, Chinghai Kao, Luigi Fontana, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 250.

https://doi.org/10.1158/1538-7445.AM2017-250

Published: 01 July 2017

View articletitled, Abstract 250: Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth

Journal Articles

Abstract 94: Association of xCT overexpression with RTKI resistance and metastases in clear cell renal cell carcinoma

Sreenivasulu Chintala, Remi Adelaiye-Ogala, Ashley Orillion, Sreevani Arisa, May Elbanna, Nur P. Damayanti, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 94.

https://doi.org/10.1158/1538-7445.AM2017-94

Published: 01 July 2017

View articletitled, Abstract 94: Association of xCT overexpression with RTKI resistance and metastases in clear cell renal cell carcinoma

Journal Articles

Abstract 4475: Delineating translocation renal cell carcinoma oncogenesis in cells harboring TFE3 fusion with spliceosome machinery associated genes

Nur P. Damayanti, Sreenivasulu Chintala, Ashley Orillion, Remi Adelaiye-Ogala, May F. Elbanna, Pete Hollenhorst, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 4475.

https://doi.org/10.1158/1538-7445.AM2017-4475

Published: 01 July 2017

View articletitled, Abstract 4475: Delineating translocation renal cell carcinoma oncogenesis in cells harboring TFE3 fusion with spliceosome machinery associated genes

Journal Articles

Abstract 897: Methionine restriction alters functional polarization of macrophages in a murine model of prostate cancer

Ashley Orillion, Remi Adelaiye-Ogala, Li Shen, Eric Ciamporcero, May Elbanna, Sreenivasulu Chintala, Sreevani Arisa, Ben Elzey, Chinghai Kao, Luigi Fontana, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 897.

https://doi.org/10.1158/1538-7445.AM2016-897

Published: 15 July 2016

View articletitled, Abstract 897: Methionine restriction alters functional polarization of macrophages in a murine model of prostate cancer

Journal Articles

Abstract 4906: The selective class I HDAC inhibitor entinostat enhances the antitumor effect of PD-1 inhibition in a syngeneic orthotopic murine model of renal cell carcinoma

Ashley R. Orillion, Li Shen, Remi Adelaiye-Ogala, May Elbanna, Sreenivasulu Chintala, Sreevani Arisa, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 4906.

https://doi.org/10.1158/1538-7445.AM2016-4906

Published: 15 July 2016

View articletitled, Abstract 4906: The selective class I HDAC inhibitor entinostat enhances the antitumor effect of PD-1 inhibition in a syngeneic orthotopic murine model of renal cell carcinoma

Journal Articles

Abstract 955: Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Sreenivasulu Chintala, Remi Adelaiye-Ogala, Ashley Orillion, Sreevani Arisa, May Elbanna, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 955.

https://doi.org/10.1158/1538-7445.AM2016-955

Published: 15 July 2016

View articletitled, Abstract 955: Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Journal Articles

Abstract 4110: Inhibition of angiopoietin 1/2 and c-MET impairs metastatic potential in a patient derived xenograft of renal carcinoma

Ashley Orillion, Remi Adelaiye-Ogala, Li Shen, Eric Ciamporcero, Sheng Yu Ku, Swathi Ramakrishnan, May Elbanna, Sreenivasulu Chintala, Roberto Pili

Cancer Res (2015) 75 (15_Supplement): 4110.

https://doi.org/10.1158/1538-7445.AM2015-4110

Published: 01 August 2015

View articletitled, Abstract 4110: Inhibition of angiopoietin 1/2 and c-MET impairs metastatic potential in a patient derived xenograft of renal carcinoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 524: An integrative approach to unveiling biomarkers and therapeutic targets identifies novel treatment strategy for advanced prostate cancer

Abstract 4409: Exploring PBX1's role in enzalutamide resistance in advanced prostate cancer

Abstract 6823: Dynamics of KMT2D modulation of the PI3K-Akt pathway and the impact on metastasis in prostate cancer

Abstract 1324: MECOM a novel player in AR-driven treatment resistant castration-resistant prostate cancer

Abstract 7584: The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma

Abstract 1953: Posttranslational modification in glucocorticoid receptor in treatment resistant prostate cancers

Abstract B003: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer

Abstract 3989: EVI1 oncogenic role in non-canonical AR driven lethal prostate cancer

Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Abstract 250: Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth

Abstract 94: Association of xCT overexpression with RTKI resistance and metastases in clear cell renal cell carcinoma

Abstract 4475: Delineating translocation renal cell carcinoma oncogenesis in cells harboring TFE3 fusion with spliceosome machinery associated genes

Abstract 897: Methionine restriction alters functional polarization of macrophages in a murine model of prostate cancer

Abstract 4906: The selective class I HDAC inhibitor entinostat enhances the antitumor effect of PD-1 inhibition in a syngeneic orthotopic murine model of renal cell carcinoma

Abstract 955: Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Abstract 4110: Inhibition of angiopoietin 1/2 and c-MET impairs metastatic potential in a patient derived xenograft of renal carcinoma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only